U.S. flag

An official website of the United States government

NM_000033.4(ABCD1):c.1865+1G>A AND Adrenoleukodystrophy

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Dec 23, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000012067.13

Allele description [Variation Report for NM_000033.4(ABCD1):c.1865+1G>A]

NM_000033.4(ABCD1):c.1865+1G>A

Gene:
ABCD1:ATP binding cassette subfamily D member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq28
Genomic location:
Preferred name:
NM_000033.4(ABCD1):c.1865+1G>A
HGVS:
  • NC_000023.11:g.153743072G>A
  • NG_009022.2:g.23205G>A
  • NG_147801.1:g.442G>A
  • NM_000033.4:c.1865+1G>AMANE SELECT
  • LRG_1017t1:c.1865+1G>A
  • LRG_1017:g.23205G>A
  • NC_000023.10:g.153008526G>A
  • NM_000033.3:c.1865+1G>A
Nucleotide change:
IVS8DS, G-A, +1
Links:
OMIM: 300371.0024; dbSNP: rs1569541198
NCBI 1000 Genomes Browser:
rs1569541198
Molecular consequence:
  • NM_000033.4:c.1865+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:
Adrenoleukodystrophy (ALD)
Synonyms:
ADDISON DISEASE AND CEREBRAL SCLEROSIS; BRONZE SCHILDER DISEASE; MELANODERMIC LEUKODYSTROPHY; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0018544; MedGen: C0162309; OMIM: 300100

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000032301OMIM
no assertion criteria provided
Pathogenic
(Dec 1, 2001)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV004298791Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Dec 23, 2022)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Characterisation of two mutations in the ABCD1 gene leading to low levels of normal ALDP.

Guimarães CP, Lemos M, Menezes I, Coelho T, Sá-Miranda C, Azevedo JE.

Hum Genet. 2001 Dec;109(6):616-22. Epub 2001 Oct 26.

PubMed [citation]
PMID:
11810273

Splicing in action: assessing disease causing sequence changes.

Baralle D, Baralle M.

J Med Genet. 2005 Oct;42(10):737-48. Review.

PubMed [citation]
PMID:
16199547
PMCID:
PMC1735933
See all PubMed Citations (4)

Details of each submission

From OMIM, SCV000032301.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

Guimaraes et al. (2001) found a splice site mutation in the ABCD1 gene which was associated with production of a small quantity of correctly spliced mRNA molecules and a small amount of ALD protein detected by Western blot analysis. The atypical and relatively mild early course of the patient was attributed to the existence of some normal ALDP. The patient was a 23-year-old man who had developed normally until the age of 9 years, when he was diagnosed with Addison disease. At that time, no neurologic involvement could be observed. Five years later, he was biochemically diagnosed with adrenoleukodystrophy (ALD; 300100); VLCFA levels were found to be increased in both plasma and skin fibroblasts. At the age of 21 years, muscular weakness and difficulty in walking led him to a new clinical evaluation; spastic paraparesis with neurophysiologic abnormalities with an altered spinal cord MRI and a normal cerebral MRI were found. Eighteen months later, the patient displayed a cerebral AMN subphenotype associated with an affected cerebellum. He was in a vegetative state at the time of report.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004298791.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Studies have shown that disruption of this splice site is associated with altered splicing resulting in multiple RNA products (PMID: 11810273). ClinVar contains an entry for this variant (Variation ID: 11315). Disruption of this splice site has been observed in individual(s) with clinical features of adrenoleukodystrophy (PMID: 11810273). This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 8 of the ABCD1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ABCD1 are known to be pathogenic (PMID: 11748843).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024